TAP block provided no clinically meaningful difference vs placebo in pain relief following minimally invasive abdominal surgery.

Continuous adductor canal block resulted in better outcomes and less need for opioids than epidural analgesia after inpatient total knee arthroplasty.

The FDA has granted Orphan Drug designation to BRC-002 (cannabidiol botanical extract) for the treatment of complex regional pain syndrome.

Among patients with poststroke pain, scrambler therapy may lead to a reduction in pain, but its long-term effect is unclear.

Globally, antibiotic consumption increased 16.3% from 2016 to 2023 and is projected to continue increasing through 2030.

Many general practitioners prescribe antibiotics for suspected CAP even when chest radiograph results are negative.

Nonoperative management is cost-effective for pediatric uncomplicated appendicitis compared with laparoscopic appendectomy.

Sixty waterborne disease outbreaks associated with splash pads were reported during 1997 to 2022, according to study findings.

The novel migraine-abortive agents lasmiditan, rimegepant, and ubrogepant effectively treated migraine pain in triptan-insufficient responders.

Naldemedine may be an effective concomitant treatment in patients with cancer who are insufficiently responsive to magnesium oxide therapy for OIC.

Neuropathic pain is common in spondyloarthritis, particularly among women and those with comorbid obesity or fibromyalgia.

Pain was frequently reported among patients with IIMs and was linked to worse clinical outcomes, increased health care utilization, and decreased heath satisfaction.